TRAVERE THERAPEUTICS, INC. Shares Outstanding (Cover Page)
TRAVERE THERAPEUTICS, INC. (TVTX) had Shares Outstanding (Cover Page) of 94.26 million shares as of 2026-07-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-04
- 2026-07-30: Entity Common Stock, Shares Outstanding 94.26M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 92.99M shares.
- 2026-02-13: Entity Common Stock, Shares Outstanding 92.24M shares.
- 2025-10-27: Entity Common Stock, Shares Outstanding 89.47M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-30 | 94.26M shares 10-Q · filed 2026-08-04 |
| 2026-04-30 | 92.99M shares 10-Q · filed 2026-05-04 |
| 2026-02-13 | 92.24M shares 10-K · filed 2026-02-19 |
| 2025-10-27 | 89.47M shares 10-Q · filed 2025-10-30 |
| 2025-07-31 | 89.14M shares 10-Q · filed 2025-08-06 |
| 2025-04-28 | 88.80M shares 10-Q · filed 2025-05-01 |
| 2025-02-18 | 88.74M shares 10-K · filed 2025-02-21 |
| 2024-10-28 | 78.05M shares 10-Q · filed 2024-10-31 |
| 2024-07-29 | 76.49M shares 10-Q · filed 2024-08-01 |
| 2024-05-02 | 76.13M shares 10-Q · filed 2024-05-06 |
| 2024-02-15 | 76.10M shares 10-K · filed 2024-02-20 |
| 2023-11-03 | 75.15M shares 10-Q · filed 2023-11-07 |
| 2023-08-01 | 75.01M shares 10-Q · filed 2023-08-03 |
| 2023-05-02 | 74.61M shares 10-Q · filed 2023-05-04 |
| 2023-02-21 | 64.74M shares 10-K · filed 2023-02-23 |
| 2022-10-25 | 64.17M shares 10-Q · filed 2022-10-27 |
| 2022-08-02 | 63.96M shares 10-Q · filed 2022-08-04 |
| 2022-05-03 | 63.51M shares 10-Q · filed 2022-05-05 |
| 2022-02-22 | 63.21M shares 10-K · filed 2022-02-24 |
| 2021-10-26 | 61.23M shares 10-Q · filed 2021-10-29 |
| 2021-07-27 | 60.72M shares 10-Q · filed 2021-07-29 |
| 2021-05-04 | 60.46M shares 10-Q · filed 2021-05-06 |
| 2021-02-24 | 60.24M shares 10-K · filed 2021-03-01 |
| 2020-11-03 | 51.05M shares 10-Q · filed 2020-11-05 |
| 2020-07-29 | 50.91M shares 10-Q · filed 2020-07-31 |
| 2020-05-07 | 43.16M shares 10-Q · filed 2020-05-11 |
| 2020-02-20 | 43.12M shares 10-K · filed 2020-02-24 |
| 2019-10-29 | 42.96M shares 10-Q · filed 2019-10-30 |
| 2019-08-05 | 42.95M shares 10-Q · filed 2019-08-06 |
| 2019-05-06 | 41.44M shares 10-Q · filed 2019-05-07 |
| 2019-02-25 | 41.41M shares 10-K · filed 2019-02-26 |
| 2018-11-01 | 41.25M shares 10-Q · filed 2018-11-01 |
| 2018-08-01 | 40.43M shares 10-Q · filed 2018-08-03 |
| 2018-04-30 | 39.94M shares 10-Q · filed 2018-07-06 |
| 2018-02-23 | 39.69M shares 10-K · filed 2018-07-06 |
| 2017-11-06 | 39.31M shares 10-Q · filed 2017-11-07 |
| 2017-08-08 | 38.39M shares 10-Q · filed 2017-08-09 |
| 2017-05-04 | 38.17M shares 10-Q · filed 2017-05-05 |
| 2017-02-28 | 38.09M shares 10-K · filed 2017-03-01 |
| 2016-11-03 | 37.73M shares 10-Q · filed 2016-11-04 |
| 2016-08-04 | 36.73M shares 10-Q · filed 2016-08-05 |
| 2016-05-04 | 36.68M shares 10-Q · filed 2016-05-05 |
| 2016-02-24 | 36.51M shares 10-K · filed 2016-02-26 |
| 2015-11-02 | 36.15M shares 10-Q · filed 2015-11-06 |
| 2015-08-04 | 35.75M shares 10-Q · filed 2015-08-10 |
| 2015-06-30 | 35.07M shares 10-Q/A · filed 2015-07-09 |
| 2015-05-01 | 34.96M shares 10-Q · filed 2015-05-11 |
| 2015-03-03 | 26.49M shares 10-K · filed 2015-03-11 |
| 2014-11-12 | 26.70M shares 10-Q · filed 2014-11-13 |
| 2014-08-12 | 26.68M shares 10-Q · filed 2014-08-14 |
| 2014-05-15 | 25.49M shares 10-Q · filed 2014-05-15 |
| 2014-03-19 | 24.26M shares 10-K · filed 2014-03-28 |
| 2013-11-12 | 18.38M shares 10-Q · filed 2013-11-13 |
| 2013-09-13 | 18.15M shares 10-K/A · filed 2013-09-16 |
| 2013-07-18 | 12.10M shares 10-Q · filed 2013-07-24 |
| 2013-05-30 | 12.07M shares 10-K · filed 2013-06-13 |
| 2013-02-28 | 12.07M shares 10-Q · filed 2013-03-06 |
| 2012-08-31 | 106.69K shares 10-Q · filed 2012-10-10 |
| 2012-05-31 | 106.69K shares 10-Q · filed 2012-08-08 |
| 2012-02-29 | 106.68K shares 10-K · filed 2012-05-24 |
| 2011-11-30 | 959.13K shares 10-Q · filed 2012-01-11 |
| 2011-08-31 | 959.13K shares 10-Q/A · filed 2012-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |